Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Medalist Diversified REIT | MDRR | 27. nov 2024 | 12.39 | +0.08 |
Medalist Diversified REIT A Pref | MDRRP | 27. nov 2024 | 27.00 | 0.00 |
Medallion Bank F Pref | MBNKP | 27. nov 2024 | 26.00 | +1.16 |
Medallion Financial | MFIN | 27. nov 2024 | 9.42 | -0.42 |
MediaAlpha | MAX | 27. nov 2024 | 12.89 | +1.26 |
Mediaco A | MDIA | 27. nov 2024 | 1.34 | -17.79 |
Medical Properties Trust | MPW | 27. nov 2024 | 4.33 | +1.64 |
MediciNova | MNOV | 27. nov 2024 | 2.01 | -3.37 |
Medicus Pharma | MDCX | 27. nov 2024 | 2.54 | 0.00 |
Medifast | MED | 27. nov 2024 | 19.44 | +6.11 |
MEDIROM Healthcare Technologies ADR | MRM | 27. nov 2024 | 3.16 | +4.96 |
MediWound | MDWD | 27. nov 2024 | 17.45 | +3.25 |
Mednax | MD | 27. nov 2024 | 14.77 | +0.14 |
Medpace | MEDP | 27. nov 2024 | 338.96 | +1.12 |
Medtronic | MDT | 27. nov 2024 | 86.27 | +0.69 |
Mega Matrix | MPU | 27. nov 2024 | 1.82 | +7.69 |
Megacap 300 Growth Index ETF Vanguard | MGK | 27. nov 2024 | 336.98 | -0.71 |
Megacap 300 Index ETF Vanguard | MGC | 27. nov 2024 | 215.02 | -0.40 |
Megacap 300 Value Index ETF Vanguard | MGV | 27. nov 2024 | 133.05 | +0.01 |
MEI Pharma | MEIP | 27. nov 2024 | 2.80 | -1.41 |
Meihua International Medical Technologies | MHUA | 27. nov 2024 | 0.54 | +2.93 |
MeiraGTx Holdings | MGTX | 27. nov 2024 | 6.55 | +2.50 |
Meiwu Technology | WNW | 27. nov 2024 | 1.00 | +4.16 |
Melar Acquisition I | MACI | 27. nov 2024 | 10.06 | +0.11 |
Melar Acquisition I | MACIU | 27. nov 2024 | 10.14 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | 27. nov 2024 | 6.20 | +3.68 |
MercadoLibre | MELI | 27. nov 2024 | 2 044.76 | -3.09 |
Mercantile Bank | MBWM | 27. nov 2024 | 50.53 | +0.86 |
Mercer International | MERC | 27. nov 2024 | 6.21 | +1.14 |
Merchants Bancorp | MBIN | 27. nov 2024 | 41.33 | -0.84 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.